Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Current Hypertension Reports
Journal
Overview
Identity
Overview
Publication Venue For
Migrating Populations and Health: Risk Factors for Cardiovascular Disease and Metabolic Syndrome
2022
An Update on Refractory Hypertension
2022
Pet Ownership and the Risk of Arterial Hypertension and Cardiovascular Disease
2022
Coffee and Arterial Hypertension
. 23.
2021
Response to “Comment’s on the Story of the Silent Killer, a History of Hypertension: Its Discovery, Diagnosis, Treatment, and Debate”
. 23.
2021
Prevention, Diagnosis, and Management of Hypertensive Disorders of Pregnancy: a Comparison of International Guidelines
. 22.
2020
The Story of the Silent Killer: A History of Hypertension: Its Discovery, Diagnosis, Treatment, and Debates
. 22.
2020
Weight Reduction for Obesity-Induced Heart Failure with Preserved Ejection Fraction
. 22.
2020
Obesity, Hypertension, and Bariatric Surgery
. 22.
2020
State of the Art: the Not-So-Great Wall of America
. 21.
2019
Epicardial Adipose Tissue and Cardiovascular Disease
. 21.
2019
Unanswered Questions Regarding Blood Pressure Management for HF Prevention
. 21.
2019
Obesity and Pulmonary Hypertension
. 20.
2018
Out of Office Blood Pressure Measurement in Pregnancy and the Postpartum Period
. 20.
2018
Novel Medical Treatments for Hypertension and Related Comorbidities
. 20.
2018
Visceral Adipose Tissue Accumulation and Residual Cardiovascular Risk
. 20.
2018
A Systematic Review of Sleep, Hypertension, and Cardiovascular Risk in Children and Adolescents
. 20.
2018
Masked Hypertension
. 19.
2017
Regression of Left Ventricular Mass After Bariatric Surgery
. 19.
2017
Sex-Specific Contributions of Endothelin to Hypertension
. 20.
2017
Isometric Handgrip as an Adjunct for Blood Pressure Control: a Primer for Clinicians
. 19.
2017
Obesity-Associated Hypertension: the Upcoming Phenotype in African-American Women
. 19.
2017
Novel Cardiac Intracrine Mechanisms Based on Ang-(1-12)/Chymase Axis Require a Revision of Therapeutic Approaches in Human Heart Disease
. 19.
2017
Pathophysiology and Potential Non-Pharmacologic Treatments of Obesity or Kidney Disease Associated Refractory Hypertension
. 19.
2017
Sleep Disordered Breathing: Hypertension and Cardiac Structure and Function
. 17.
2015
Mechanisms Influencing Circadian Blood Pressure Patterns Among Individuals with HIV
. 17.
2015
Inflammation and Hypertension: New Understandings and Potential Therapeutic Targets
. 17.
2014
Alterations in cardiac structure and function in hypertension
. 16.
2014
Angiotensin-(1-12): A chymase-mediated cellular angiotensin II substrate
. 16.
2014
Therapy of acute hypertension in hospitalized children and adolescents
. 16.
2014
Vitamin D deficiency in the pathogenesis of hypertension: Still an unsettled question
. 16.
2014
Mechanisms of lipotoxicity in the cardiovascular system
. 14:517-531.
2012
Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease
. 14:152-159.
2012
Vitamin D therapy and cardiovascular health
. 13:187-191.
2011
A stitch saves time and lowers blood pressure
. 12:146-148.
2010
Heme oxygenase and renal disease
. 11:56-62.
2009
Beyond brachial pressure effect.
. 10:213-215.
2008
Neurohormonal regulation of the sympathetic nervous system: New insights into central mechanisms of action
. 10:233-240.
2008
Leptin and mechanisms of endothelial dysfunction and cardiovascular disease.
. 10:434-439.
2008
Are current guidelines optimal for treatment of blood pressure in patients with coronary artery disease?
. 9:211-213.
2007
Uric acid and hypertension
. 8:111-115.
2006
Circadian rhythms in cardiac gene expression
. 5:445-453.
2003
Effects of hormone replacement therapy on the sympathetic nervous system and blood pressure
. 5:241-246.
2003
Do angiotensin receptor antagonists have benefits beyond blood pressure lowering?
. 4:219-220.
2002
Effects of ACE inhibitors, calcium antagonists, and other blood pressure-lowering drugs
. 3:227-228.
2001
Health outcomes associated with calcium antagonists
. 3:228-229.
2001
The role of the nervous system in hypertension
. 3:255-262.
2001
Aldosterone-related genetic effects in hypertension
. 2:295-301.
2000
Antihypertensive drug therapy in the third millennium: Are there benefits beyond blood pressure?
. 2:291-294.
2000
Recent outcome trials of newer antihypertensives
. 1:238-240.
1999
The epithelial sodium channel in hypertension
. 1:158-163.
1999
The role of the central nervous system in hypertension
. 1:246-253.
1999
Identity
International Standard Serial Number (issn)
1522-6417
Electronic International Standard Serial Number (eissn)
1534-3111